Additionally, over-expression of BMP7 could inhibit NLRP3 inflammasome activation and pyroptosis of NPCs to ameliorate IDD in T1DM (Fig. 8), which emphasizes the potential value of BMP7 in diabetic IDD therapy. This evidence concerns the gene NLRP3 and intervertebral disk degenerative disorder.